|
ZNF800 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.12687636999453E-13 |
| Normal-vs-Stage2 |
2.10180000070892E-08 |
| Normal-vs-Stage3 |
4.86666262844437E-12 |
| Normal-vs-Stage4 |
8.27760082700024E-12 |
| Stage1-vs-Stage2 |
6.202800E-01 |
| Stage1-vs-Stage3 |
1.705400E-01 |
| Stage1-vs-Stage4 |
2.747600E-02 |
| Stage2-vs-Stage3 |
6.413200E-01 |
| Stage2-vs-Stage4 |
1.767600E-01 |
| Stage3-vs-Stage4 |
3.198200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.33146835171283E-15 |
| Normal-vs-AfricanAmerican |
3.187300E-04 |
| Normal-vs-Asian |
4.74350003720758E-09 |
| Caucasian-vs-AfricanAmerican |
3.401200E-01 |
| Caucasian-vs-Asian |
8.432200E-01 |
| AfricanAmerican-vs-Asian |
3.417600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03090885722668E-14 |
| Normal-vs-Female |
1.65023550380283E-12 |
| Male-vs-Female |
2.228800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.42660344543333E-11 |
| Normal-vs-Age(41-60Yrs) |
2.66453525910038E-15 |
| Normal-vs-Age(61-80Yrs) |
4.17520462647758E-11 |
| Normal-vs-Age(81-100Yrs) |
1.704610E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.621800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.901600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.717400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.381400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.926600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.749000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.823600E-02 |
| Classical-VS-Follicular |
5.763600E-02 |
| Classical-VS-Other |
1.257420E-01 |
| Classical-VS-Normal |
3.49764661677909E-12 |
| Tall-VS-Follicular |
4.905400E-01 |
| Tall-VS-Other |
5.639200E-01 |
| Tall-VS-Normal |
5.79389980437384E-10 |
| Follicular-VS-Other |
3.791800E-01 |
| Follicular-VS-Normal |
1.50309764634926E-11 |
| Other-VS-Normal |
2.835600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83106871279415E-14 |
| Normal-vs-N1 |
7.13289982634535E-10 |
| N0-vs-N1 |
6.576200E-01 |
|
|
